Juan A. Pineda
Juan A. Pineda
Hospital Universitario de Valme. Facultad de Medicina. Universidad de Sevilla.
Verified email at - Homepage
Cited by
Cited by
HIV coinfection shortens the survival of patients with hepatitis C virus‐related decompensated cirrhosis
JA Pineda, M Romero‐Gómez, F Díaz‐García, JA Girón‐González, ...
Hepatology 41 (4), 779-789, 2005
Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus
J Macías, J Berenguer, MA Japón, JA Girón, A Rivero, LF López‐Cortés, ...
Hepatology 50 (4), 1056-1063, 2009
Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapy
JA Pineda, JA García‐García, M Aguilar‐Guisado, MJ Ríos‐Villegas, ...
Hepatology 46 (3), 622-630, 2007
The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection
S Vergara, J Macías, A Rivero, A Gutiérrez-Valencia, M González-Serrano, ...
Clinical infectious diseases 45 (8), 969-974, 2007
Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease
N Merchante, JA Girón-González, M González-Serrano, J Torre-Cisneros, ...
Aids 20 (1), 49-57, 2006
HCV epidemiology in high-risk groups and the risk of reinfection
H Midgard, A Weir, N Palmateer, VL Re III, JA Pineda, J Macías, ...
Journal of hepatology 65 (1), S33-S45, 2016
Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine
J Macías, V Castellano, N Merchante, RB Palacios, JA Mira, C Sáez, ...
Aids 18 (5), 767-774, 2004
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ...
Nature communications 12 (1), 3417, 2021
Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors
A Rivero, JA Mira, JA Pineda
Journal of antimicrobial chemotherapy 59 (3), 342-346, 2007
Prediction of Response to Pegylated Interferon plus Ribavirin by IL28B Gene Variation in Patients Coinfected with HIV and Hepatitis C Virus
JA Pineda, A Caruz, A Rivero, K Neukam, I Salas, A Camacho, P José C, ...
Clinical Infectious Diseases 51 (7), 788-795, 2010
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir
E Vispo, P Barreiro, JA Pineda, JA Mira, I Maida, L Martín-Carbonero, ...
Antiviral therapy 13 (3), 429-438, 2008
Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes
J Macías, JA Girón-González, M González-Serrano, D Merino, P Cano, ...
Gut 55 (3), 409-414, 2006
A common polymorphism in TLR3 confers natural resistance to HIV-1 infection
M Sironi, M Biasin, R Cagliani, D Forni, M De Luca, I Saulle, S Lo Caputo, ...
The Journal of Immunology 188 (2), 818-823, 2012
Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ ACE project
S Moreno‐Grau, I De Rojas, I Hernández, I Quintela, L Montrreal, ...
Alzheimer's & Dementia 15 (10), 1333-1347, 2019
Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin
K Neukam, P Barreiro, J Macías, A Avellón, C Cifuentes, ...
Clinical infectious diseases 57 (3), 465-468, 2013
High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack
J Macías, RB Palacios, E Claro, J Vargas, S Vergara, JA Mira, ...
Liver International 28 (6), 781-786, 2008
Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat …
C Orkin, JM Molina, E Negredo, JR Arribas, J Gathe, JJ Eron, ...
The Lancet HIV 5 (1), e23-e34, 2018
Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
FJ Medrano, J Hernández-Quero, E Jiménez, JA Pineda, A Rivero, ...
Aids 6 (12), 1499-1504, 1992
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus–coinfected patients with compensated cirrhosis
JA Mira, A Rivero-Juárez, LF López-Cortés, JA Girón-González, F Téllez, ...
Clinical Infectious Diseases 56 (11), 1646-1653, 2013
Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy
J Macias, I Melguizo, F Fernández-Rivera, A Garcia-Garcia, J Mira, ...
European Journal of Clinical Microbiology and Infectious Diseases 21, 775-781, 2002
The system can't perform the operation now. Try again later.
Articles 1–20